David Raben Bicara Therapeutics Inc. (BCAX) insider trading activity

Shares Held (Direct Ownership) 55.3K

n/a 3M change

n/a 12M change

Total Value Held N/A

David Raben Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 26 2025	BUY Exercise of conversion of derivative security	$75,000 $3.79 p/Share	19,789 Added 26.36%	55,286 Common Stock
Nov 25 2025	SELL Open market or private sale	$103,620 $18.84 p/Share	5,500 Reduced 13.42%	35,497 Common Stock
Nov 25 2025	BUY Exercise of conversion of derivative security	$20,845 $3.79 p/Share	5,500 Added 13.13%	36,403 Common Stock
Nov 24 2025	SELL Open market or private sale	$101,475 $18.45 p/Share	5,500 Reduced 13.42%	35,497 Common Stock
Nov 24 2025	BUY Exercise of conversion of derivative security	$20,845 $3.79 p/Share	5,500 Added 11.83%	40,997 Common Stock
Oct 09 2025	SELL Open market or private sale	$405,900 $18.45 p/Share	22,000 Reduced 38.26%	35,497 Common Stock
Oct 09 2025	BUY Exercise of conversion of derivative security	$83,380 $3.79 p/Share	22,000 Added 27.67%	57,497 Common Stock

Chief Medical Officer

Boston, MA

Receive a notification when an Institution or Guru buys or sells BCAX shares.

Notify only if

Value

Get notified when an Bicara Therapeutics Inc. insider buys or sells BCAX shares.

Notify only if

Operation

Value

Type

Receive news related to Bicara Therapeutics Inc.